Variables

n

Death

Univariate analysis

p-value

Multivariate model

p-value

Age (ans)

0.0109*

0.0666

<60

22

36.4% (8/22)

-

≥60

21

76.2% (16/21)

5.6 [1.56 - 22.9]

2.8 [1.14 - 19.3]

Gender

0.4431

Female

9

44.4% (4/9)

-

-

Male

34

58.8% (20/34)

1.7 [0.4 - 8.3]

-

Comorbidities

Hypertension

25

56% (14/25)

1.0 [0.3 - 3.4]

0.9

Diabetes

15

46.7% (7/15)

0.5 [0.1 - 2]

0.3787

Clinical signs

Hypotension

1

0

-

0.4418

Fever

7

85.7% (6/7)

6.8 [1 - 137]

0.09

Respiratory distress

26

73.1% (19/26)

19 [2.7 - 39]

0.01*

1.36 [1.5 - 3.8]

0.7917

Biological signs

Haemoglobin < 12 g/dl

16

62.5% (10/16)

1.5 [0.4 - 5.7]

0.4978

Hyperkalemia

12

75% (9/12)

3 [0.7 - 15.7]

0.1517

Uremia (g/l)

0.4332

<2

22

50% (11/22)

-

≥2

21

61.9% (13/21)

1.6 [0.4 - 5.6]

0.4332

CRP (mg/l)

<30

4

¼ (25%)

-

[30 - 60[

8

3/8 (37.5%)

1.8 [0.1 - 46.2]

0.6670

≥60

27

19/27 (70.4%)

7.1 [0.7 - 156.8]

0.1102

CT lesions

Interstitial

42

57.1% (24/42)

+

0.9944

Alveolar

30

63.3% (19/30)

2.8 [0.7 - 11.2]

0.1375

Pleurisy

20

55% (11/20)

0.9 [0.3 - 3.1]

0.9202

KDIGO stage

0.04964

1

9

77.8% (7/9)

-

-

2

9

22.2% (2/9)

0.08 [0 - 0.6]

0.14 [0 - 0.1]

0.0148*

3

25

60% (15/25)

0.4 [1.1 - 2.2]

0.7 [0 - 0.1]

0.0492*

Type of kidney involvement

0.5374

FKI

14

42.8% (6/14)

-

NTA

10

60% (6/10)

2.2 [0.6 - 9.8]

Not determined

19

63.2% (12/19)

2 [0.3 - 11.1]

Duration of the disease

0.5953

<7 days

6

66.7% (4/6)

-

≥7 days

37

54.1% (20/37)

0.6 [0.1 - 3.4]

Treatment

Antibiotics

40

52.5% (21/40)

-

0.2425

Anticoagulants

28

60.7% (17/28)

1.7 [0.4 - 6]

0.3787

Corticosteroids

28

53.6% (15/28)

0.7 [0.2 - 2.7]

0.6861

Vasoactive amines

15

86.7% (13/15)

10 [2.2 - 72.7]

0.0068*

0.6 [0.2 - 3.9]

0.2975

Invasive ventilation

19

89.5% (17/19)

20 [4.4 - 154.7]

<0.001*

22.5 [8.7 - 207.7]

0.0120*

Hemodialysis

21

52.4% (11/21)

0.7 [0.2 - 2.5]

0.6581